Navigation Links
Dr. David Williams Scoops National Media on PSA Effectiveness -- by 17 Years

The reliability of the PSA test is something that Dr. David Williams has been questioning since 1992.

Potomac, MD (PRWEB) April 27, 2009 -- The effectiveness of the ubiquitous PSA test -- in both predicting cancer and saving lives -- was recently scrutinized in articles appearing in the Washington Post and New York Times. The reliability of this test is something that Dr. David Williams has been questioning since 1992.

The PSA test, which measures the level of prostate-specific antigen secreted by the prostate gland, can result in false positives that lead to unnecessary physical intervention. And the studies cited in the articles indicate little-to-no life-saving results based on PSA screenings.

"PSA in itself does not diagnose cancer," said Dr. Williams. "Although cancerous prostate glands do secrete more PSA, when PSA levels are used to diagnose cancer they give incorrect results 25 to 30 percent of the time. Not only do they miss detecting some cancers, they may imply that someone has cancer when he actually doesn't."

Dr. Williams focuses on maintaining a healthy prostate through a combination of natural nutrients that promote healthy prostate tissue and function, as well as normal urinary function and flow, and provide antioxidant protection for the prostate tissue while maintaining a healthy hormonal balance in the body.

Dr. Williams continued, "Mainstream medicine is finally realizing that this test is not the final word on prostate health--and that will be good for men's health. I recognize that most men over age 50 will die with prostate cancer; however, very few will die from it. So we should be focusing on maintaining a healthy prostate through non-invasive measures. Even the test's originator, Dr. Thomas Stamey, acknowledges that the test, while promising in the beginning, is no longer a useful or reliable marker for detecting prostate cancer."

About Dr. Williams:
Dr. David Williams has spent over 25 years in the medical field and is a leading authority on natural healing. He is a graduate of Southwest Texas State University and Texas Chiropractic College. Until 1985, Dr. Williams operated the largest non-invasive alternative medical practice in central Texas. At that time, he devoted his full time and energy to sharing his health discoveries from around the world through his newsletter, Alternatives. Often years ahead of conventional medicine, Dr. Williams was a proponent of a low-fat diet long before the American Heart Association endorsed it; reported on "60 Minutes" about the ability of shark cartilage to reverse cancer growth without side effects; and was among the first to warn about overuse of antibiotics leading to resistant strains of disease. Over 20 years later, Alternatives has been devoted to alternative medicine with more than 230,000 subscribers. To find out more about Dr. Williams, his philosophy, and his supplements, please visit:


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. David Mack Joins Ameritox as Vice President for Human Resources
2. David Kaye Launches a New Facilities Services Company to Assist the Growing Biotechnology Business in Maryland
3. Adds David Southwick as SVP of Sales and Service
4. Former Head of Office of Lilly CME, Steve Davidson, RPh, Named Medical Education Specialist at CME Enterprise
5. AstraZenecas David Brennan Elected PhRMA Board Chairman
6. Dr. Norman E. Rosenthal Joins Paul McCartney and David Lynch at Press Conference for Benefit Concert
7. eHealth Initiative Applauds Appointment of David Blumenthal as New National Coordinator for Health Information Technology
8. Dr. Barry Friedberg comments on David vs. Goliath: Whos Really in the Pursuit of Patient Safety & Satisfaction?
9. Media Advisory: Medco CEO David B. Snow Jr. To Address American Enterprise Institute: Health IT: Empowering Precision Medicine
10. David Teuscher, MD, Elected Secretary of Academy Board of Councilors
11. Veteran Rehab Specialist, David Glancy, Joins Fast-Growing Alliance Seating & Mobility in Michigan
Post Your Comments:
(Date:11/27/2015)... ... 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces ... This is one of Joplin's most famous and beautiful concert posters. The concert was ... in Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's ...
(Date:11/26/2015)... MI (PRWEB) , ... November 26, 2015 , ... ... for substance abuse located in central Michigan, have come together on Thanksgiving Day ... specially produced video, available for viewing on the Serenity Point YouTube channel, patients ...
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
(Date:11/26/2015)... San Antonio, TX (PRWEB) , ... November 26, 2015 , ... ... accomplishment! On November 19, 2015, our surgeons performed their 6,000th free flap breast ... Ledoux , “We wake up every day excited to rebuild lives and it’s an ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology: